---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-035672"
form_type: "8-K"
ticker: "BIAF"
cik: "0001712762"
company_name: "bioAffinity Technologies, Inc."
filed_at: "2026-07-31T21:15:15+00:00"
generated_at: "2026-07-31T21:16:06.236545+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# bioAffinity receives Nasdaq delisting notice for bid price non-compliance; plans appeal

## Summary
- Received Staff Determination on July 30, 2026, for bid price below $1.00 for 30 consecutive business days.
- Not eligible for 180-day compliance period due to reverse stock split within prior year (1-for-30 on Sept 19, 2025).
- Intends to appeal on August 6, 2026, which will stay delisting pending panel decision.
- No assurance of regaining compliance or continued listing on Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001493152-26-035672
- form_type: 8-K
- ticker: BIAF
- cik: 0001712762
- company_name: bioAffinity Technologies, Inc.
- filed_at: 2026-07-31T21:15:15+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1712762/000149315226035672/0001493152-26-035672-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1712762/000149315226035672/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-035672
- JSON: https://secwatch.observer/filing/0001493152-26-035672.json
- Plain text: https://secwatch.observer/filing/0001493152-26-035672.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.